Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Gaber, Alexander ^a   Stene, Christina ^a   Hotakainen, Kristina ^b   Nodin, Björn ^a   Palmquist, Ingrid ^a   Bjartell, Anders ^a   Stenman, Ulf Håkan ^b   Jeppsson, Bengt ^a   Johnson, Louis B ^a   Jirström, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Biomarker; Prognosis; Radio therapy; Rectal cancer; TATI; Tissue micro array

Indexed keywords

APROTININ; CARCINOEMBRYONIC ANTIGEN; CREATININE; TUMOR MARKER;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; FEMALE; FLUOROMETRY; HUMAN; IMMUNOFLUOROMETRY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; PROTEIN EXPRESSION; RANK SUM TEST; RECTUM CANCER; RECTUM SURGERY; BIOSYNTHESIS; BLOOD; DNA MICROARRAY; METABOLISM; METHODOLOGY; MIDDLE AGED; RADIOTHERAPY; RECEIVER OPERATING CHARACTERISTIC; RECTUM TUMOR; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RADIOTHERAPY; RECTAL NEOPLASMS; REGRESSION ANALYSIS; ROC CURVE; TREATMENT OUTCOME; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TUMOR MARKERS, BIOLOGICAL;

EID: 80052038904     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-100     Document Type: Article

References (21)

1. Gaber A, Johansson M, Stenman UH, Hotakainen K, Ponten F, Glimelius B, Bjartell A, Jirstrom K, Birgisson H. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer 2009, 100:1540-1548. 10.1038/sj.bjc.6605047, 2696764, 19384300.
2. Gaber A, Nodin B, Hotakainen K, Nilsson E, Stenman UH, Bjartell A, Birgisson H, Jirstrom K. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients. BMC Cancer 2010, 10:498. 10.1186/1471-2407-10-498, 2946315, 20849596.
3. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650. 10.1200/JCO.2005.08.144, 16110023.
4. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997, 336:980-987.
5. Angenete E, Oresland T, Falk P, Breimer M, Hultborn R, Ivarsson ML. Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components. Acta Oncol 2009, 1-9.
6. Yarnold J. Molecular aspects of cellular responses to radiotherapy. Radiother Oncol 1997, 44:1-7. 10.1016/S0167-8140(97)00049-2, 9288850.
7. Kumar A, Collins HM, Scholefield JH, Watson SA. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer. Br J Cancer 2000, 82:960-965. 10.1054/bjoc.1999.1025, 2374410, 10732772.
8. Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M, Stenman UH. Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 1991, 51:2107-2112.
9. Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, Nosho K, Min Y, Horiuchi S, Yoshida M, Itoh F, Imai K. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003, 199:176-184. 10.1002/path.1277, 12533830.
10. Huhtala ML, Pesonen K, Kalkkinen N, Stenman UH. Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 1982, 257:13713-13716.
11. Turpeinen U, Koivunen E, Stenman UH. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion. Biochem J 1988, 254:911-914. 1135171, 2461702.
12. Stenman UH. Tumour-associated trypsin inhibitor and tumour-associated trypsin. Scand J Clin Lab Invest Suppl 1990, 201:93-101.
13. Gouyer V, Fontaine D, Dumont P, de Wever O, Fontayne-Devaud H, Leteurtre E, Truant S, Delacour D, Drobecq H, Kerckaert JP, et al. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene 2008, 27:4024-4033. 10.1038/onc.2008.42, 18317448.
14. Greene F, Page D, Fleming I, et al. AJCC Cancer Staging Manual 2002, New York: Springer-Verlag, 6.
15. Osman S, Turpeinen U, Itkonen O, Stenman UH. Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods 1993, 161:97-106. 10.1016/0022-1759(93)90201-H, 8486933.
16. Goldstein NS, Bosler D. An approach to interpreting immunohistochemical stains of adenocarcinoma in small needle core biopsy specimens: the impact of limited specimen size. Am J Clin Pathol 2007, 127:273-281. 10.1309/ATHVF5R4CQUKB7LX, 17210515.
17. American_Cancer_Society Colorectal cancer: facts and figure 2008-1010. American_Cancer_Society.
18. Tramonti G, Donadio C, Ferdeghini M, Annichiarico C, Norpoth M, Bianchi R, Bianchi C. Serum tumour-associated trypsin inhibitor (TATI) and renal function. Scand J Clin Lab Invest 1996, 56:653-656. 10.3109/00365519609090601, 8981662.
19. Unsal Kilic D, Uner A, Akyurek N, Erpolat P, Dursun A, Pak Y. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:196-203. 10.1016/j.ijrobp.2006.08.010, 17071013.
20. Aldulaymi B, Christensen IJ, Soletormos G, Jess P, Nielsen SE, Laurberg S, Brunner N, Nielsen HJ. Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer. Anticancer Res 30:4755-4759.
21. Solakidi S, Dessypris A, Stathopoulos GP, Androulakis G, Sekeris CE. Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies. Clin Biochem 2004, 37:56-60. 10.1016/j.clinbiochem.2003.09.002, 14675563.